Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20190506043492N5Phase 3Completed
Phase 3, randomised, double-blind trial comparing Etomidate induction, Propofol induction and Thiopental control (3 arms). Primary endpoints: Serum interleukin-1 level, Serum interleukin-6 level and 4 more. Started Jul 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20190506043492N5.